Interestingly, however, the detected SERPINB2 mutation is predicted to result in a stop and therefore the expression of a functional SERPINB2 protein would be lost in those PSCs in pancreatic cancer. This evidence concerns the gene SERPINB2 and familial pancreatic carcinoma.